Apr 20, 2020
Creative Medical Technology Holdings is Granted Patent on Mesenchymal Stem Cells for Female Infertility Pending Quayle Action
Mar 11, 2020
Creative Medical Technology Holdings Announces IMMCELZ(TM) Adoptive Immunotherapy Product
Feb 13, 2020
Creative Medical Technology Holdings, Inc. February 2020 Shareholder Update
Aug 05, 2019
Creative Medical Technology Holdings, Inc. August 2019 Shareholder Update
May 06, 2019
CaverStem Stem Cell Treatment Of Erectile Dysfunction Receives Additional International Exposure
Feb 20, 2018
Creative Medical Technology Holdings Licenses Intellectual Property from Internationally Renowned Neurologist and Creates Neurology Focused Stem Cell Subsidiary
Dec 20, 2017
Stem Cells as Medicine: The Promise of Universal Donor Adult Stem Cells Continues to Attract Optimism
Dec 18, 2017
"Urologist to the Stars" Dr. Alexander Gershman Begins Treating Patients with Patented Caverstem(TM) Stem Cell Procedure for Drug Refractory Erectile Dysfunction
Dec 14, 2017
Creative Medical Technology Holdings Recruits Top Urologists for Caverstem(TM) Stem Cell Treatment of Erectile Dysfunction
Oct 16, 2017
Creative Medical Technology Holdings Expands Stem Cell Therapeutic Platform by Entry into Field of Stroke and Neurodegeneration
Aug 28, 2017
Creative Medical Technology Holdings Achieves 100% Patient Enrollment in CaverstemTM Clinical Trial for Stem Cell Treatment of Erectile Dysfunction
Jul 25, 2017
Creative Medical Technology Holdings Demonstrates AmnioStem Derived Exosomes Inhibit Glioma Growth
Jun 21, 2017
Creative Medical Technology Holdings Adds Immune Modulatory Cells for Stimulation of Perispinal Angiogenesis to Induce Regeneration of Degenerated Discs
Jun 07, 2017
Creative Medical Technology Holdings Develops Platform Aimed at Augmenting All Mesenchymal Stem Cell Therapies for Lower Back Pain